In this study, the production of IL-6 in the SSc fibroblasts was enhanced by both NE and the ARβ agonist, isoproterenol, but not the ARα agonist, oxymetazoline, suggesting that the NE-induced IL-6 production is primarily mediated via ARβ. Here, IL6 is linked to systemic sclerosis.